Andrew A. Shelton, M.D.
Clinical Trials
- Not Recruiting Parastomal Reinforcement With Strattice
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
- Not Recruiting A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
- Not Recruiting Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
- Recruiting Molecular Genetic and Pathological Studies of Anal Tumors
- Recruiting Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
- Not Recruiting Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
- Not Recruiting Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
- Not Recruiting Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
Help